VNTR Polymorphisms of the Serotonin Transporter and Dopamine Transporter Genes in Male Opiate Addicts

VNTR polymorphisms of the serotonin transporter (hSERT) and dopamine transporter (DAT1) gene were studied in male opiate addicts. Samples of ethnic Russians and ethnic Tatars did not differ in genotype and allele frequencies. Homozygosity at hSERT (especially 10/10) was associated with early opiate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular biology (New York) 2002-07, Vol.36 (4), p.462-466
Hauptverfasser: Galeeva, A R, Gareeva, A E, Yur'ev, E B, Khusnutdinova, E K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 466
container_issue 4
container_start_page 462
container_title Molecular biology (New York)
container_volume 36
creator Galeeva, A R
Gareeva, A E
Yur'ev, E B
Khusnutdinova, E K
description VNTR polymorphisms of the serotonin transporter (hSERT) and dopamine transporter (DAT1) gene were studied in male opiate addicts. Samples of ethnic Russians and ethnic Tatars did not differ in genotype and allele frequencies. Homozygosity at hSERT (especially 10/10) was associated with early opiate addiction, while genotype 12/10 proved to be protective. In the case of DAT1, genotype 9/9 was associated with early opiate addiction. The combination of hSERT genotype 10/10 with DAT1 genotype 10/10 was shown to be a risk factor of opiate abuse under 16 years of age.[PUBLICATION ABSTRACT]
doi_str_mv 10.1023/A:1019883806620
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_904466064</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>904466064</sourcerecordid><originalsourceid>FETCH-LOGICAL-c258t-8a52c18306ef32e7cf8fa980b238ee8cc570ec7d9aa4ff2138e4e4d3e38b8d793</originalsourceid><addsrcrecordid>eNpdkM1LxDAUxIMouK6evQYvnqovH01Tb8uqq7C6oqvXJZu-sl3apCbpwf_egl4UBgbe_BgeQ8g5gysGXFzPbhiwUmuhQSkOB2TCFOhMcJkfkgkAV5kuhTgmJzHuAdgoPiH48bx-pS--_ep86HdN7CL1NU07pG8YfPKucXQdjIu9DwkDNa6it743XePwT7BAh5GO9JNpka76xiSks6pqbIqn5Kg2bcSzX5-S9_u79fwhW64Wj_PZMrM81ynTJueWaQEKa8GxsLWuTalhy4VG1NbmBaAtqtIYWdecjVeJshIo9FZXRSmm5PKntw_-c8CYNl0TLbatceiHuClBSqVAyZG8-Efu_RDc-NymUOM4OYNCfAPMaWY5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>760105107</pqid></control><display><type>article</type><title>VNTR Polymorphisms of the Serotonin Transporter and Dopamine Transporter Genes in Male Opiate Addicts</title><source>Springer Nature - Complete Springer Journals</source><creator>Galeeva, A R ; Gareeva, A E ; Yur'ev, E B ; Khusnutdinova, E K</creator><creatorcontrib>Galeeva, A R ; Gareeva, A E ; Yur'ev, E B ; Khusnutdinova, E K</creatorcontrib><description>VNTR polymorphisms of the serotonin transporter (hSERT) and dopamine transporter (DAT1) gene were studied in male opiate addicts. Samples of ethnic Russians and ethnic Tatars did not differ in genotype and allele frequencies. Homozygosity at hSERT (especially 10/10) was associated with early opiate addiction, while genotype 12/10 proved to be protective. In the case of DAT1, genotype 9/9 was associated with early opiate addiction. The combination of hSERT genotype 10/10 with DAT1 genotype 10/10 was shown to be a risk factor of opiate abuse under 16 years of age.[PUBLICATION ABSTRACT]</description><identifier>ISSN: 0026-8933</identifier><identifier>EISSN: 1608-3245</identifier><identifier>DOI: 10.1023/A:1019883806620</identifier><language>eng</language><publisher>New York: Springer Nature B.V</publisher><subject>Dopamine ; Genotype &amp; phenotype ; Methadone ; Substance abuse treatment</subject><ispartof>Molecular biology (New York), 2002-07, Vol.36 (4), p.462-466</ispartof><rights>MAIK "Nauka/Interperiodica" 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c258t-8a52c18306ef32e7cf8fa980b238ee8cc570ec7d9aa4ff2138e4e4d3e38b8d793</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Galeeva, A R</creatorcontrib><creatorcontrib>Gareeva, A E</creatorcontrib><creatorcontrib>Yur'ev, E B</creatorcontrib><creatorcontrib>Khusnutdinova, E K</creatorcontrib><title>VNTR Polymorphisms of the Serotonin Transporter and Dopamine Transporter Genes in Male Opiate Addicts</title><title>Molecular biology (New York)</title><description>VNTR polymorphisms of the serotonin transporter (hSERT) and dopamine transporter (DAT1) gene were studied in male opiate addicts. Samples of ethnic Russians and ethnic Tatars did not differ in genotype and allele frequencies. Homozygosity at hSERT (especially 10/10) was associated with early opiate addiction, while genotype 12/10 proved to be protective. In the case of DAT1, genotype 9/9 was associated with early opiate addiction. The combination of hSERT genotype 10/10 with DAT1 genotype 10/10 was shown to be a risk factor of opiate abuse under 16 years of age.[PUBLICATION ABSTRACT]</description><subject>Dopamine</subject><subject>Genotype &amp; phenotype</subject><subject>Methadone</subject><subject>Substance abuse treatment</subject><issn>0026-8933</issn><issn>1608-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkM1LxDAUxIMouK6evQYvnqovH01Tb8uqq7C6oqvXJZu-sl3apCbpwf_egl4UBgbe_BgeQ8g5gysGXFzPbhiwUmuhQSkOB2TCFOhMcJkfkgkAV5kuhTgmJzHuAdgoPiH48bx-pS--_ep86HdN7CL1NU07pG8YfPKucXQdjIu9DwkDNa6it743XePwT7BAh5GO9JNpka76xiSks6pqbIqn5Kg2bcSzX5-S9_u79fwhW64Wj_PZMrM81ynTJueWaQEKa8GxsLWuTalhy4VG1NbmBaAtqtIYWdecjVeJshIo9FZXRSmm5PKntw_-c8CYNl0TLbatceiHuClBSqVAyZG8-Efu_RDc-NymUOM4OYNCfAPMaWY5</recordid><startdate>20020701</startdate><enddate>20020701</enddate><creator>Galeeva, A R</creator><creator>Gareeva, A E</creator><creator>Yur'ev, E B</creator><creator>Khusnutdinova, E K</creator><general>Springer Nature B.V</general><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20020701</creationdate><title>VNTR Polymorphisms of the Serotonin Transporter and Dopamine Transporter Genes in Male Opiate Addicts</title><author>Galeeva, A R ; Gareeva, A E ; Yur'ev, E B ; Khusnutdinova, E K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c258t-8a52c18306ef32e7cf8fa980b238ee8cc570ec7d9aa4ff2138e4e4d3e38b8d793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Dopamine</topic><topic>Genotype &amp; phenotype</topic><topic>Methadone</topic><topic>Substance abuse treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Galeeva, A R</creatorcontrib><creatorcontrib>Gareeva, A E</creatorcontrib><creatorcontrib>Yur'ev, E B</creatorcontrib><creatorcontrib>Khusnutdinova, E K</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Molecular biology (New York)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Galeeva, A R</au><au>Gareeva, A E</au><au>Yur'ev, E B</au><au>Khusnutdinova, E K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>VNTR Polymorphisms of the Serotonin Transporter and Dopamine Transporter Genes in Male Opiate Addicts</atitle><jtitle>Molecular biology (New York)</jtitle><date>2002-07-01</date><risdate>2002</risdate><volume>36</volume><issue>4</issue><spage>462</spage><epage>466</epage><pages>462-466</pages><issn>0026-8933</issn><eissn>1608-3245</eissn><abstract>VNTR polymorphisms of the serotonin transporter (hSERT) and dopamine transporter (DAT1) gene were studied in male opiate addicts. Samples of ethnic Russians and ethnic Tatars did not differ in genotype and allele frequencies. Homozygosity at hSERT (especially 10/10) was associated with early opiate addiction, while genotype 12/10 proved to be protective. In the case of DAT1, genotype 9/9 was associated with early opiate addiction. The combination of hSERT genotype 10/10 with DAT1 genotype 10/10 was shown to be a risk factor of opiate abuse under 16 years of age.[PUBLICATION ABSTRACT]</abstract><cop>New York</cop><pub>Springer Nature B.V</pub><doi>10.1023/A:1019883806620</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-8933
ispartof Molecular biology (New York), 2002-07, Vol.36 (4), p.462-466
issn 0026-8933
1608-3245
language eng
recordid cdi_proquest_miscellaneous_904466064
source Springer Nature - Complete Springer Journals
subjects Dopamine
Genotype & phenotype
Methadone
Substance abuse treatment
title VNTR Polymorphisms of the Serotonin Transporter and Dopamine Transporter Genes in Male Opiate Addicts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A34%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=VNTR%20Polymorphisms%20of%20the%20Serotonin%20Transporter%20and%20Dopamine%20Transporter%20Genes%20in%20Male%20Opiate%20Addicts&rft.jtitle=Molecular%20biology%20(New%20York)&rft.au=Galeeva,%20A%20R&rft.date=2002-07-01&rft.volume=36&rft.issue=4&rft.spage=462&rft.epage=466&rft.pages=462-466&rft.issn=0026-8933&rft.eissn=1608-3245&rft_id=info:doi/10.1023/A:1019883806620&rft_dat=%3Cproquest%3E904466064%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=760105107&rft_id=info:pmid/&rfr_iscdi=true